scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.CANLET.2012.08.016 |
P698 | PubMed publication ID | 22922215 |
P50 | author | Peter Leung | Q56224384 |
P2093 | author name string | Man-Tat Lau | |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | ovarian cancer | Q172341 |
P304 | page(s) | 191-198 | |
P577 | publication date | 2012-08-21 | |
P1433 | published in | Cancer Letters | Q326372 |
P1476 | title | The PI3K/Akt/mTOR signaling pathway mediates insulin-like growth factor 1-induced E-cadherin down-regulation and cell proliferation in ovarian cancer cells | |
P478 | volume | 326 |
Q92579754 | A network pharmacology-based study on the anti-hepatoma effect of Radix Salviae Miltiorrhizae |
Q89129566 | A panel of three oxidative stress-related genes predicts overall survival in ovarian cancer patients received platinum-based chemotherapy |
Q58572666 | Aclidinium inhibits proliferation and metastasis of ovarian cancer SKOV3 cells via downregulating PI3K/AKT/mTOR signaling pathway |
Q38983986 | Activation of the PI3K/Akt/mTOR/p70S6K pathway is involved in S100A4-induced viability and migration in colorectal cancer cells |
Q55023785 | Adiponectin Reverses the Proliferative Effects of Estradiol and IGF-1 in Human Epithelial Ovarian Cancer Cells by Downregulating the Expression of Their Receptors. |
Q38952915 | Amphiregulin induces human ovarian cancer cell invasion by down-regulating E-cadherin expression |
Q49379642 | BCL6B suppresses proliferation and migration of colorectal carcinoma cells through inhibition of the PI3K/AKT signaling pathway |
Q38656691 | BLID: A Novel Tumor-Suppressor Gene |
Q37337868 | Bleomycin induces endothelial mesenchymal transition through activation of mTOR pathway: a possible mechanism contributing to the sclerotherapy of venous malformations |
Q34154752 | Brucine suppresses colon cancer cells growth via mediating KDR signalling pathway |
Q35633988 | Cardamonin Inhibits Metastasis of Lewis Lung Carcinoma Cells by Decreasing mTOR Activity |
Q37133643 | Centrosomal Protein of 55 Regulates Glucose Metabolism, Proliferation and Apoptosis of Glioma Cells via the Akt/mTOR Signaling Pathway. |
Q91906673 | Chemotherapy Resistance in Advanced Ovarian Cancer Patients |
Q36734197 | Drug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation |
Q41592971 | Effect and mechanism of inhibition of PI3K/Akt/mTOR signal pathway on chronic neuropathic pain and spinal microglia in a rat model of chronic constriction injury |
Q92962981 | Effect of Dexmedetomidine-Mediated Insulin-Like Growth Factor 2 (IGF2) Signal Pathway on Immune Function and Invasion and Migration of Cancer Cells in Rats with Ovarian Cancer |
Q57944891 | Expression and Intracellular Localization of ACA and TRA-1-81 in Smooth Muscle Cell Tumors |
Q94547358 | Fasting to enhance Cancer treatment in models: the next steps |
Q34648726 | Fibroblast growth factor 2 induces E-cadherin down-regulation via PI3K/Akt/mTOR and MAPK/ERK signaling in ovarian cancer cells |
Q38737164 | GAB2 promotes cell proliferation by activating the ERK signaling pathway in hepatocellular carcinoma |
Q34294117 | Genetic and dietary determinants of insulin-like growth factor (IGF)-1 and IGF binding protein (BP)-3 levels among Chinese women |
Q47727030 | IGF-1 promotes angiogenesis in endothelial cells/adipose-derived stem cells co-culture system with activation of PI3K/Akt signal pathway. |
Q35774760 | IGF1 stimulates crypt expansion via differential activation of 2 intestinal stem cell populations |
Q35044404 | Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer |
Q37615957 | Inhibition of mTORC1 induces loss of E-cadherin through AKT/GSK-3β signaling-mediated upregulation of E-cadherin repressor complexes in non-small cell lung cancer cells |
Q37047940 | Insulin and insulin-like growth factor signaling increases proliferation and hyperplasia of the ovarian surface epithelium and decreases follicular integrity through upregulation of the PI3-kinase pathway |
Q36873574 | Insulin-like growth factor--phosphatidylinositol 3 kinase signaling in canine cortisol-secreting adrenocortical tumors |
Q40543955 | Ketamine Increases Permeability and Alters Epithelial Phenotype of Renal Distal Tubular Cells via a GSK-3β-Dependent Mechanism. |
Q33714747 | MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cells |
Q37379265 | Maternal high-fat diet induces hyperproliferation and alters Pten/Akt signaling in prostates of offspring |
Q36716306 | Maternal supplementation of diabetic mice with thymoquinone protects their offspring from abnormal obesity and diabetes by modulating their lipid profile and free radical production and restoring lymphocyte proliferation via PI3K/AKT signaling. |
Q35133254 | Meloxicam executes its antitumor effects against hepatocellular carcinoma in COX-2- dependent and -independent pathways |
Q41193504 | MiR-503 modulates epithelial-mesenchymal transition in silica-induced pulmonary fibrosis by targeting PI3K p85 and is sponged by lncRNA MALAT1 |
Q35077900 | MicroRNA-10b promotes nucleus pulposus cell proliferation through RhoC-Akt pathway by targeting HOXD10 in intervertebral disc degeneration |
Q37423551 | MicroRNA-346 facilitates cell growth and metastasis, and suppresses cell apoptosis in human non-small cell lung cancer by regulation of XPC/ERK/Snail/E-cadherin pathway. |
Q89761376 | Mitogen-Activated Protein Kinase (MAPK) and Obesity-Related Cancer |
Q91599060 | Optogenetic control of epithelial-mesenchymal transition in cancer cells |
Q39131597 | Overexpression of c-Abl predicts unfavorable outcome in epithelial ovarian cancer |
Q64054027 | PGC-1β cooperating with FOXA2 inhibits proliferation and migration of breast cancer cells |
Q52642387 | PHD-finger domain protein 5A functions as a novel oncoprotein in lung adenocarcinoma. |
Q47153446 | PKM2 in carcinogenesis and oncotherapy |
Q36962691 | Polycomb complex protein BMI-1 promotes invasion and metastasis of pancreatic cancer stem cells by activating PI3K/AKT signaling, an ex vivo, in vitro, and in vivo study. |
Q39051376 | Potential biomarkers for paclitaxel sensitivity in hypopharynx cancer cell |
Q34494513 | Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets? |
Q38760614 | Proteomic Screening and Lasso Regression Reveal Differential Signaling in Insulin and Insulin-like Growth Factor I (IGF1) Pathways. |
Q42647696 | Simultaneous NF-κB inhibition and E-cadherin upregulation mediate mutually synergistic anticancer activity of celastrol and SAHA in vitro and in vivo. |
Q64070858 | Stimulative role of ST6GALNAC1 in proliferation, migration and invasion of ovarian cancer stem cells via the Akt signaling pathway |
Q64062557 | Suppressing growth and invasion of human hepatocellular carcinoma cells by celecoxib through inhibition of cyclooxygenase-2 |
Q35023562 | TGFβ signaling in myeloid cells regulates mammary carcinoma cell invasion through fibroblast interactions |
Q92702379 | The Communication Between the PI3K/AKT/mTOR Pathway and Y-box Binding Protein-1 in Gynecological Cancer |
Q55225058 | The effect of the type of dietary protein on the development of ovarian cancer. |
Q26852910 | The links between insulin resistance, diabetes, and cancer |
Q38206587 | The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer |
Q38953433 | Tumour biology of obesity-related cancers: understanding the molecular concept for better diagnosis and treatment. |
Q35832914 | XPC inhibits NSCLC cell proliferation and migration by enhancing E-Cadherin expression |
Search more.